Partnership between Eyenavision and Avulux offers elevated patient care and accelerated practice growth opportunities for eyecare providers PITTSBURGH/MIAMI – Aug. 19, 2024 – Eyenavision and Avulux...
Avulux vs. FL-41: What ECPs Need To Know
Many ECPs have heard of FL-41 – a generic tint formulation that has been used by lens manufacturers since the early 1990s – developed for patients with an aversion to the flickering of fluorescent ...
Brant Southwell Joins Avulux As Chief Commercial Officer
Avulux, the innovator behind the only clinically proven lens that blocks the harmful light wavelengths linked to migraine attacks, today announced that Brant Southwell has joined the company as Chi...
Avulux Partners With IDOC, Offering Competitive Advantage To Independent-Owner Optometrists
Avulux is proud to announce our official partnership with IDOC, a service-focused alliance committed to the success of all independent-owner optometrists. As an official vendor partner of IDOC, all...
Avulux Welcomes John A. Moran Eye Center To Its Family Of Providers
Avulux, the innovator behind the world’s only clinically proven lens for people living with migraine and light sensitivity, is pleased to welcome the John A. Moran Eye Center to its growing network...
Migraine Awareness Month: Optometry’s Vital Role
Did you know that June is Migraine Awareness Month? We’d bet that as many as one in five of your patients know – because they experience migraine themselves. As an optometrist, you can play a vital...